Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Bershteyn

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 9, 2011
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccineAnna Bershteyn, Melissa C Hanson, Monica P Crespo, et al.
Systematic Reviews|May 8, 2019
Demographic and risk group heterogeneity across the UNAIDS 90-90-90 targets: a systematic review and meta-analysis protocolDylan Green, Brenda Kharono, Diana M Tordoff, et al.
JAMA Network Open|April 16, 2025
Six-Week Problem Area-Concordant vs 8-Week Problem Area-Discordant Group Interpersonal Psychotherapy: A Randomized Clinical TrialRosco Kasujja, Peter Birungi, Kasturi Bhamidipati, et al.
Journal of the International AIDS Society|March 11, 2020
Evidence of sociodemographic heterogeneity across the HIV treatment cascade and progress towards 90-90-90 in sub-Saharan Africa - a systematic review and meta-analysisDylan Green, Diana M Tordoff, Brenda Kharono, et al.
BMJ Open|July 31, 2025
Comparison of HIV self-test distribution modalities to reduce HIV transmission and burden in western Kenya: a mathematical modelling studyHae-Young Kim, Ingrid Eshun-Wilson, Daniel Bridenbecker, et al.
Plos One|December 31, 2020
Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provisionEdinah Mudimu, Kathryn Peebles, Zindoga Mukandavire, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2021
Large age shifts in HIV-1 incidence patterns in KwaZulu-Natal, South AfricaAdam Akullian, Alain Vandormael, Joel C Miller, et al.
The Lancet. HIV|September 23, 2024
Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysisLinxuan Wu, David Kaftan, Rachel Wittenauer, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2026
Using HIV antibody measurements to detect viral load rebound: analysis from an analytic treatment interruption study in the United StatesAnna Bershteyn, Shiying You, Adam Epstein-Shuman, et al.
Journal of Infection and Public Health|August 5, 2025
Does prioritization of COVID vaccine distribution to communities with the highest COVID burden reduce health inequity?Hae-Young Kim, Anna Bershteyn, Rienna Russo, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 9, 2011
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccineAnna Bershteyn, Melissa C Hanson, Monica P Crespo, et al.
Systematic Reviews|May 8, 2019
Demographic and risk group heterogeneity across the UNAIDS 90-90-90 targets: a systematic review and meta-analysis protocolDylan Green, Brenda Kharono, Diana M Tordoff, et al.
JAMA Network Open|April 16, 2025
Six-Week Problem Area-Concordant vs 8-Week Problem Area-Discordant Group Interpersonal Psychotherapy: A Randomized Clinical TrialRosco Kasujja, Peter Birungi, Kasturi Bhamidipati, et al.
Journal of the International AIDS Society|March 11, 2020
Evidence of sociodemographic heterogeneity across the HIV treatment cascade and progress towards 90-90-90 in sub-Saharan Africa - a systematic review and meta-analysisDylan Green, Diana M Tordoff, Brenda Kharono, et al.
BMJ Open|July 31, 2025
Comparison of HIV self-test distribution modalities to reduce HIV transmission and burden in western Kenya: a mathematical modelling studyHae-Young Kim, Ingrid Eshun-Wilson, Daniel Bridenbecker, et al.
Plos One|December 31, 2020
Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provisionEdinah Mudimu, Kathryn Peebles, Zindoga Mukandavire, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2021
Large age shifts in HIV-1 incidence patterns in KwaZulu-Natal, South AfricaAdam Akullian, Alain Vandormael, Joel C Miller, et al.
The Lancet. HIV|September 23, 2024
Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysisLinxuan Wu, David Kaftan, Rachel Wittenauer, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2026
Using HIV antibody measurements to detect viral load rebound: analysis from an analytic treatment interruption study in the United StatesAnna Bershteyn, Shiying You, Adam Epstein-Shuman, et al.
Journal of Infection and Public Health|August 5, 2025
Does prioritization of COVID vaccine distribution to communities with the highest COVID burden reduce health inequity?Hae-Young Kim, Anna Bershteyn, Rienna Russo, et al.
Pageof 10